Generic Name
PegfilgrastimPacks Price
- In Pack
Neulasta
Therapeutic Group
ImmunostimulantsIndication Dosage
Pegfilgrastim is a medication used to reduce the risk of infection in patients undergoing chemotherapy for certain types of cancer. It is prescribed to stimulate the production of white blood cells in the body, helping to prevent infections that may occur as a side effect of chemotherapy treatment.
Reduction In Duration Of Neutropenia And Incidence Of Febrile Neutropenia In Cytotoxic Chemotherapy For Malignancy:
By Sc Inj:
- Adult: 6 Mg For Each Chemotherapy Cycle, To Be Started At Least 24 Hours After Chemotherapy.
- Children: Not Recommended.
Content
- Inj 6mg: Per 0.6 ml: Pegfilgrastim 6mg; Pre-Filled Syringes.
Pregnancy
Risk Cannot Be Ruled Out, Use Only If Extremely Necessary.
Stability
- Recombinant G-csf (recombinant Human Granulocyte-colony Stimulating Factor)
Contra Indications
- Hypersensitivity To E. Coli Derived Proteins, Secondary Acute Or Chronic Leukaemia, Myelodysplastic Syndrome.
Precautions
- Hypersensitivity To E. Coli Derived Proteins, Secondary Acute Or Chronic Leukaemia, Myelodysplastic Syndrome.
Lactation
- Contraindicated or Not Recommended.
Side Effects
- Skeletal
- Joint And Muscle Pain
- Inj Site Pain
- Non-cardiac Chest Pain
- Headache
- Splenomegaly
- Reversible Elevated Uric Acid
- Allergic Reactions Including Anaphylaxis
- Capillary Leak Syndrome (including Fatal Cases). Rare; Splenic Rupture
Available Brands
Author
Shahid Arif